The 2025 bid season marked the first year of Phase III in the Medicare Advantage VBID program. This phase unveils new requirements and options for MA plans, along with a revamped application process and a competitive bidding rubric.
Join our expert panelists as they delve into these pivotal Phase III developments, offering valuable insights and addressing the challenges faced from the recent bid cycle. Gain from their shared lessons and explore CMS’s latest evaluation of VBID program outcomes. Discover the future trajectory of VBID and its transformative implications for the Medicare Advantage competitive landscape.